Cargando…

Hormetic effect of rotenone in primary human fibroblasts

BACKGROUND: Rotenone inhibits the electron transfer from complex I to ubiquinone, in this way interfering with the electron transport chain in mitochondria. This chain of events induces increased levels of intracellular reactive oxygen species, which in turn can contribute to acceleration of telomer...

Descripción completa

Detalles Bibliográficos
Autores principales: Marthandan, Shiva, Priebe, Steffen, Groth, Marco, Guthke, Reinhard, Platzer, Matthias, Hemmerich, Peter, Diekmann, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4572608/
https://www.ncbi.nlm.nih.gov/pubmed/26380578
http://dx.doi.org/10.1186/s12979-015-0038-8
_version_ 1782390413927120896
author Marthandan, Shiva
Priebe, Steffen
Groth, Marco
Guthke, Reinhard
Platzer, Matthias
Hemmerich, Peter
Diekmann, Stephan
author_facet Marthandan, Shiva
Priebe, Steffen
Groth, Marco
Guthke, Reinhard
Platzer, Matthias
Hemmerich, Peter
Diekmann, Stephan
author_sort Marthandan, Shiva
collection PubMed
description BACKGROUND: Rotenone inhibits the electron transfer from complex I to ubiquinone, in this way interfering with the electron transport chain in mitochondria. This chain of events induces increased levels of intracellular reactive oxygen species, which in turn can contribute to acceleration of telomere shortening and induction of DNA damage, ultimately resulting in aging. In this study, we investigated the effect of rotenone treatment in human fibroblast strains. RESULTS: For the first time we here describe that rotenone treatment induced a hormetic effect in human fibroblast strains. We identified a number of genes which were commonly differentially regulated due to low dose rotenone treatment in fibroblasts independent of their cell origin. However, these genes were not among the most strongly differentially regulated genes in the fibroblast strains on treatment with rotenone. Thus, if there is a common hormesis regulation, it is superimposed by cell strain specific individual responses. We found the rotenone induced differential regulation of pathways common between the two fibroblast strains, being weaker than the pathways individually regulated in the single fibroblast cell strains. Furthermore, within the common pathways different genes were responsible for this different regulation. Thus, rotenone induced hormesis was related to a weak pathway signal, superimposed by a stronger individual cellular response, a situation as found for the differentially expressed genes. CONCLUSION: We found that the concept of hormesis also applies to in vitro aging of primary human fibroblasts. However, in depth analysis of the genes as well as the pathways differentially regulated due to rotenone treatment revealed cellular hormesis being related to weak signals which are superimposed by stronger individual cell-internal responses. This would explain that in general hormesis is a small effect. Our data indicate that the observed hormetic phenotype does not result from a specific strong well-defined gene or pathway regulation but from weak common cellular processes induced by low levels of reactive oxygen species. This conclusion also holds when comparing our results with those obtained for C. elegans in which the same low dose rotenone level induced a life span extending, thus hormetic effect. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12979-015-0038-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4572608
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45726082015-09-18 Hormetic effect of rotenone in primary human fibroblasts Marthandan, Shiva Priebe, Steffen Groth, Marco Guthke, Reinhard Platzer, Matthias Hemmerich, Peter Diekmann, Stephan Immun Ageing Research BACKGROUND: Rotenone inhibits the electron transfer from complex I to ubiquinone, in this way interfering with the electron transport chain in mitochondria. This chain of events induces increased levels of intracellular reactive oxygen species, which in turn can contribute to acceleration of telomere shortening and induction of DNA damage, ultimately resulting in aging. In this study, we investigated the effect of rotenone treatment in human fibroblast strains. RESULTS: For the first time we here describe that rotenone treatment induced a hormetic effect in human fibroblast strains. We identified a number of genes which were commonly differentially regulated due to low dose rotenone treatment in fibroblasts independent of their cell origin. However, these genes were not among the most strongly differentially regulated genes in the fibroblast strains on treatment with rotenone. Thus, if there is a common hormesis regulation, it is superimposed by cell strain specific individual responses. We found the rotenone induced differential regulation of pathways common between the two fibroblast strains, being weaker than the pathways individually regulated in the single fibroblast cell strains. Furthermore, within the common pathways different genes were responsible for this different regulation. Thus, rotenone induced hormesis was related to a weak pathway signal, superimposed by a stronger individual cellular response, a situation as found for the differentially expressed genes. CONCLUSION: We found that the concept of hormesis also applies to in vitro aging of primary human fibroblasts. However, in depth analysis of the genes as well as the pathways differentially regulated due to rotenone treatment revealed cellular hormesis being related to weak signals which are superimposed by stronger individual cell-internal responses. This would explain that in general hormesis is a small effect. Our data indicate that the observed hormetic phenotype does not result from a specific strong well-defined gene or pathway regulation but from weak common cellular processes induced by low levels of reactive oxygen species. This conclusion also holds when comparing our results with those obtained for C. elegans in which the same low dose rotenone level induced a life span extending, thus hormetic effect. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12979-015-0038-8) contains supplementary material, which is available to authorized users. BioMed Central 2015-09-16 /pmc/articles/PMC4572608/ /pubmed/26380578 http://dx.doi.org/10.1186/s12979-015-0038-8 Text en © Marthandan et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Marthandan, Shiva
Priebe, Steffen
Groth, Marco
Guthke, Reinhard
Platzer, Matthias
Hemmerich, Peter
Diekmann, Stephan
Hormetic effect of rotenone in primary human fibroblasts
title Hormetic effect of rotenone in primary human fibroblasts
title_full Hormetic effect of rotenone in primary human fibroblasts
title_fullStr Hormetic effect of rotenone in primary human fibroblasts
title_full_unstemmed Hormetic effect of rotenone in primary human fibroblasts
title_short Hormetic effect of rotenone in primary human fibroblasts
title_sort hormetic effect of rotenone in primary human fibroblasts
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4572608/
https://www.ncbi.nlm.nih.gov/pubmed/26380578
http://dx.doi.org/10.1186/s12979-015-0038-8
work_keys_str_mv AT marthandanshiva hormeticeffectofrotenoneinprimaryhumanfibroblasts
AT priebesteffen hormeticeffectofrotenoneinprimaryhumanfibroblasts
AT grothmarco hormeticeffectofrotenoneinprimaryhumanfibroblasts
AT guthkereinhard hormeticeffectofrotenoneinprimaryhumanfibroblasts
AT platzermatthias hormeticeffectofrotenoneinprimaryhumanfibroblasts
AT hemmerichpeter hormeticeffectofrotenoneinprimaryhumanfibroblasts
AT diekmannstephan hormeticeffectofrotenoneinprimaryhumanfibroblasts